Phase II pilot randomized trial of zonisamide for disease modification in prodromal Lewy body disease. - Hiraga K; Hattori M; Tamakoshi D; Satake Y; Fukushima T; Saito Y; Uematsu T; Tsuboi T; Sato M; Yokoi K; Suzuki K; Arahata Y; et al. (NPJ Parkinson's disease, 2025)